Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 2, 2026 | ZhiTai Biotech | $72.8M Series C | OrbiMed | BlueRun Ventures, Haoyue Capital, Huagai Capital, Qiming Venture Partners, Taifu Capital, Wuyuan Capital |
| Feb 11, 2026 | BCIFlex | $43.4M BCIFlex Series A | — | Baidu Ventures, Beijing Pharmaceutical and Health Industry Investment Fund, DragonBall Capital, Hongshan Capital Group (Sequoia Capital China), IDG Capital, Jia Yin Capital, Legend Capital, Shunwei Capital, Yuan Sheng Capital |